Brief: Fusion Pharmaceuticals Announces Q1 2023 Financial Results, Clinical Program Updates
11/05/2023 13:00
May 11 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND CLINICAL PROGRAM UPDATES
* FUSION PHARMACEUTICALS - $20.0 MILLION PRIVATE PLACEMENT
FINANCING WITH FEDERATED HERMES KAUFMANN FUNDS EXTENDS CASH
RUNWAY INTO Q2 2025
* FUSION PHARMACEUTICALS - AS OF MARCH 31, HELD CASH, CASH
EQUIVALENTS AND INVESTMENTS OF $221.2 MILLION
* QTRLY NET LOSS PER SHARE $0.45
* Q1 EARNINGS PER SHARE VIEW $-0.32 -- REFINITIV IBES DATA
Source text for Eikon: ID:nCNWgLDHNa
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary